ARTICLE | Company News
Pharmagenesis, Pierre Fabre deal
March 24, 2003 8:00 AM UTC
Pierre Fabre's Pierre Fabre Medicament division received rights to develop, manufacture and market PG490-88Na worldwide, excluding Taiwan, China and Hong Kong. Pharmagenesis said preclinical studies ...